Search

everythinglearnresearchcommunity

for

Search:↓

Nanotechnology improves hair care products by enhancing ingredient stability, targeting treatment, and reducing side effects, but more research on its toxicity is needed.

New treatments for severe alopecia areata show promise but lack standard approval.

Skin diseases are common and can significantly affect people's lives; better outcome measures and ethical clinical trials are needed to improve dermatology care.

Biomaterials with MSC-derived substances could improve tissue repair and have advantages over direct cell therapy.

Stress and emotional factors can worsen skin conditions by affecting the immune system.

Hair follicle stem cells and skin cells show promise for hair and skin therapies but need more research for clinical use.

The new nanocomposite films are stronger, protect against UV, speed up wound healing, and are antibacterial without being toxic.

Spaceflight can harm skin health by altering gene expression, affecting DNA, mitochondria, and skin barriers.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

AP-2α and AP-2β proteins are essential for healthy adult skin and hair.

Skin tumor regression is helped by retinoic acid signaling blocking Wnt signaling.

The document concludes that various childhood hair and nail disorders exist, some may improve on their own, and advances in genetics and immunology could enhance treatment and counseling.

Photodynamic therapy can remove nonpigmented hair in mice and might work for humans.

Patients with fewer past treatments for alopecia areata respond better to baricitinib.

Laser therapy might help regrow hair in alopecia totalis better than steroids alone.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Activated PRP effectively increases hair density and reduces hair loss in alopecia.

The document concludes that the development of certain tumors is influenced by genetic background and that a specific gene modification can lead to tumor regression and reduced growth.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Lichen planus may be associated with a higher risk of metabolic syndrome.

Methotrexate effectively treated a 2-year-old's generalized pustular psoriasis without side effects.

A new treatment called SAMiRNA-AR68 increases hair count in people with hair loss, showing similar results to existing treatments but without side effects.

JAK inhibitors show promise for treating various skin diseases.

Oral Vitamin D can improve hair density and reduce hair loss in Telogen Effluvium patients.

Allergic rhinitis increases hair loss risk, but antihistamines can reduce it.

Nanomaterials can improve hair care products and treatments, including hair loss and alopecia, by enhancing stability and safety, and allowing controlled release of compounds, but their safety in cosmetics needs more understanding.

A new engineered treatment shows promise in curing heart fibrosis.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Aortic aneurysm treatment has shifted to less invasive methods, improving safety and outcomes.

Effective PCOS treatments require targeting specific signaling pathways.